a fresh look for csanz€¦ · professor xiaowei wang baker heart and diabetes institute, melbourne...

15
The Society’s logo has been a source of much discussion over the years and there have been attempts to introduce a new logo design, all of which were unsuccessful. We know that the animals depicted in the logo are disproportionate - a kiwi is not the same size as a kangaroo - but our members have embraced the logo as an enduring symbol of the Society. As a senior Fellow of the Society once said, “we know the logo is corny but we love it all the same!” The logo in its current form was introduced in 1988 but it was not the first iteration of the logo. The inaugural logo comprised the kangaroo and the kiwi, representing Australia and New Zealand, and a red heart under a sun. The second version (1988) removed the sun and the form of the animals was changed so they were standing upright. At its November meeting, the Board approved a refreshed design of the CSANZ logo. The key elements of the kangaroo, kiwi and heart have been retained but the design is simpler, modern and better able to be translated to creative digital formats. While the kiwi may still be the same size as the kangaroo it is important to note that the message that this image portrays is one of equality, that is, the Society is committed to the promotion of the highest standards of education, training, research and practice in cardiovascular medicine, surgery, nursing and allied health subjects, and the promotion of equitable access to high quality cardiovascular healthcare for all Australians and New Zealanders. December 2017 Volume XXIX, No 4 A fresh look for CSANZ Editorial by Professor Stephen Nicholls Inside this issue: CSANZ- Boehringer Ingelheim CV Research Innovation Grants 3 Membership changes and new Members 4 CSANZ Office Holiday Closure 2 CSANZ 2018 & ANZET18 5-6 Travelling Fellowship Reports 8, 9 12 & 13 Scholarships and Travel Grants Travelling Fellowship Applications: ACC 2018 CSANZ Heart Failure Council Travel Grant Applications: ESCHeart Failure Meeting ISHLT Conference on the pulse Inaugural CSANZ Logo 1988 refreshed CSANZ Logo

Upload: others

Post on 10-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

The Society’s logo has been a source of much discussion over the years and

there have been attempts to introduce a new logo design, all of which were

unsuccessful. We know that the animals depicted in the logo are

disproportionate - a kiwi is not the same size as a kangaroo - but our

members have embraced the logo as an enduring symbol of the Society. As

a senior Fellow of the Society once said, “we know the logo is corny but we

love it all the same!”

The logo in its current form was introduced in 1988 but it was not the first

iteration of the logo. The inaugural logo comprised the kangaroo and the

kiwi, representing Australia and New Zealand, and a red heart under a

sun. The second version (1988) removed the sun and the form of the

animals was changed so they were standing upright.

At its November meeting, the Board approved a refreshed design of the

CSANZ logo. The key elements of the kangaroo, kiwi and heart have been

retained but the design is simpler, modern and better able to be translated

to creative digital formats.

While the kiwi may still be the same size as the kangaroo it is important to

note that the message that this image portrays is one of equality, that is,

the Society is committed to the promotion of the highest standards of

education, training, research and practice in cardiovascular medicine,

surgery, nursing and allied health subjects, and the promotion of equitable

access to high quality cardiovascular healthcare for all Australians and

New Zealanders.

December 2017 Volume XXIX, No 4

A fresh look for CSANZ Editorial by Professor Stephen Nicholls

Inside this issue:

CSANZ-

Boehringer

Ingelheim CV

Research

Innovation

Grants

3

Membership

changes and

new Members

4

CSANZ Office

Holiday Closure

2

CSANZ 2018 &

ANZET18

5-6

Travelling

Fellowship

Reports

8, 9

12 &

13

Scholarships and

Travel Grants

Travelling

Fellowship

Applications:

ACC 2018

CSANZ Heart

Failure Council

Travel Grant

Applications:

ESC—Heart

Failure Meeting

ISHLT

Conference

on the pulse

Inaugural CSANZ Logo 1988 refreshed CSANZ Logo

Page 2: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 2 On the pulse December 2017 Page 2

CSANZ OFFICE CLOSURE

The CSANZ will be closed from

noon Friday 22 December

and will re-open on

Tuesday, 2 January, 2018

To all our members and their families,

the Editor and staff wish you all

a safe and happy festive season

And a very happy and healthy 2018.

Page 3: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 3 On the pulse December 2017

2017 CSANZ-Boehringer Ingelheim Cardiovascular

Research Innovation Grants

Research Grant—$50K

Dr Jodie Ingles

Centenary Institute, Sydney

Project Title: Clinical and Genetic Predictors of

Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Jodie’s study is the first to investigate the impact of modifiable risk factors such as hyper-

tension, obesity, obstructive sleep apnoea and diabetes on the development of atrial fibrilla-

tion in patients with hypertrophic cardiomyopathy, an inherited condition which thickens

the wall of the heart muscle, impairing the body’s ability to pump blood.

Research Grant—$50K

Professor Xiaowei Wang

Baker Heart and Diabetes Institute,

Melbourne

Project Title: Towards Effective and Safe

Thrombolysis and Thromboprophylaxis: Activated-

platelet targeted fibrinolytic drugs for safe and

bleeding-free therapy.

Xiaowei’s grant will be used to advance the development of new approaches for the diag-

nosis and treatment of thrombotic and embolic events, such as myocardial infarction,

stroke and venous thromboembolism, using novel recombinant antibody targeting.

Page 4: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 4 On the pulse December 2017

Affiliate Members

Miss J Adsett (QLD), Mr T Agbaedeng (SA),

Miss L Assink (NZ), Ms U Balzat (NZ), Ms L

Barwell (NZ), Miss V Beatie (VIC), Mrs G

Black (QLD), Miss R Chapanduka (VIC), Mrs

W Coleman (NZ), Dr K Du Plessis (VIC), Ms

K Eagleson (QLD), Mrs D Earl (SA), Ms K

Easton (VIC), Dr G Fonini (WA), Ms E

Gibbons (NZ), Mrs D Hampson (NZ), Mr A

Heinrich (NZ), Ms C Hinz (QLD), Mrs D

Horlock (NZ), Mr Md H Imam (SA), Mr G

Jenkins (WA), Mrs D J Kaur (NZ), Ms A

Keates (VIC), Mrs S Kurian (WA), Ms C

Labrosciano (SA), Miss J Lancaster (NZ), Mr

C Luther (QLD), Mrs J McDonagh (NSW), Ms

R McGoldrick (NZ), Mrs S Meredith (QLD),

Mrs L Moodie (NZ), Mrs J Moss (QLD), Dr S

Nandra (NZ), Ms G Noyer (NZ), Mrs M

Oldfield (NZ), Miss M Panovska (VIC), Dr S

Pasupathy (SA), Mrs R Peters (QLD), Miss S

Prosper (QLD), Mrs J Roseingrave (NZ), Mrs

K Rowley (QLD), Miss K Satija (NZ), Ms S

Scott (QLD), Mrs W Shamoail (VIC), Ms A

Singleton (NSW), Mrs L Smith (QLD), Mrs C

Staite (NSW), Mrs M Stevens (NZ), Ms J Suna

(QLD), Ms D Te Wiata (NZ), Mrs T

Thompson (VIC), Mrs A Townsend (QLD),

Mrs E Tyler (VIC), Ms C Whitfield (NSW),

Mrs A Williams (QLD), Ms L Wilson (NZ),

Ms J Youard (NZ) and Mrs H Young (QLD).

Associate Members

Dr C Ada (NSW), Dr J Antony (QLD), Dr A

Brown (VIC), Dr N Aroney (QLD), Dr A Bhat

(NSW), Dr M Burrage (QLD), Dr K Cheng

(TAS), Dr J H Chong (NSW), Dr K Chung

(WA), Dr T Deshmukh (NSW), Dr E Doherty

(NZ), Dr A Doost (ACT), Dr H Fernando

(VIC), Dr S Hungerford (NSW), Dr K Hyasat

(QLD), Dr B Jahangiri (NZ), Dr K Kearney

(NSW), Dr A Khurana (NZ), Dr A Lee (NSW),

Dr A Lin (VIC), Mr D McCormack (NZ), Dr L

McDowall (NSW), Dr A Michael (NZ), Dr A

Morton (WA), Dr A Murphy (VIC), Dr S

Nanayakkara (VIC), Dr M O’Connor (NZ), Dr

S Parfrey (VIC), Dr K Y Peck (VIC), Dr S

Peters (VIC), Dr J Phan (NSW), Dr S Plunkett

(NZ), Dr U Ponangi (WA), Dr D Russell

(VIC), Dr R Samuel (VIC), Dr A Saraswat

(QLD), Dr L Selkrig (VIC), Dr D Selvakumar

(NSW), Dr I Shiekh (WA), Dr N Song (NSW),

Dr P Thaneeru (NZ), Dr S Trivedi (NSW) and

Dr F Zaky (NSW).

FCSANZ Members

Dr S Aldous (NZ), Dr A Al-Fiadh (VIC), Dr A

Almeida (VIC), Dr S Burgess (NSW), Dr J

Chiha (NSW), Dr G Clare (NZ), Dr R Cordina

(NSW), Dr M Daly (NZ), Dr P Ding (NZ), Dr

M Fung (NSW), Dr W Harrison (NZ), Dr N

Htun (VIC), A/Prof P Kistler (VIC), Prof I

Konstantinov (VIC), Dr S Kumar (NSW), Dr T

Lancefield (VIC), Dr Y Liu (NSW), Dr R

Mahajan (SA), Dr M Menon (NZ), Dr K

Muthiah (NSW), Dr K Negishi (TAS), Dr J

Otton (NSW), Dr V Pera (NZ), Dr K Prados

(NSW), Dr R Prakash (NT), Dr A Puri (NZ),

Dr M Santos (SA), Dr E Shaw (NSW), Dr S

Sidharta (NSW), Dr D Smyth (NZ), Dr J

Somaratne (NZ), Dr L Wang (NSW), Dr M

Webber (NZ), Dr M Wheeler (NZ) and Dr C Y

Yu (NSW).

Membership Changes and Additions

The following changes and new admissions to Membership occurred at the May, August and November

2017 Board meetings. The Society extends a warm welcome to all.

Page 5: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 5 On the pulse December 2017

Abstract submission

Now Open

Abstract submission close

1 March 2018

Registration open

7 March 2018

Earlybird registration close

31 May 2018

Key Dates

Named Lecturers

R T Hall Lecturer John Cleland

Kempson Maddox Lecturer Anushka Patel

Victor Chang Memorial Lecturer Patrick Perier

Gaston Bauer Lecturer David Celermajer

Basic Science Lecturer David James

Cardiovascular Nursing Lecturer Judith Finn

2-5 August 2018, Brisbane, QLD

www.csanzasm.com

Page 6: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 6 On the pulse December 2017

2-5 August 2018, Brisbane, QLD

www.anzet.com.au

ANZET 2018, 2-5 August, Brisbane Convention Centre

NEW for 2018

ANZET and the CSANZ ASM will be held over the same dates in 2018.

International Faculty confirmed to date: Louis Bernstein Lecturer: David Kandzari, Piedmont Heart Institute, Atlanta, USA Julinda Mehilli, German Heart Centre, Munich, Germany Stéphane Rinfret, McGill University Health Centre, Montreal, Canada

Sandra Lauck, St Paul’s Hospital, Vancouver, Canada

ANZET Structural Heart Nurses Symposium - Thursday 2 August, 2018

This meeting is open to: Cath Lab Nurses, Structural Co-ordinators and Allied Health staff.

Page 7: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 7 On the pulse December 2017

Applications are called for the CSANZ

Travelling Fellowships for travel grants to

enable investigators to attend the 67th Annual

Scientific Session of the American College of

Cardiology to be held in Orlando, Florida,

from 10 - 12 March, 2018. The Fellowships are

intended to provide an opportunity for

investigators in the early stage of their research

career, to present at a major international

conference.

The conditions are:

1. The Fellowships are valued at up to

AU$3,000 each.

2. At the time of application, applicants must

be current financial FCSANZ, Associate or

Affiliate Members of the Cardiac Society,

with preference given to those attending

their first meeting.

3. The work must have emanated from

Australia or New Zealand.

4. Applicants must have an abstract accepted

for presentation at the ACC meeting and

must be the first or senior author of the

accepted abstract. In some circumstances,

consideration may be given to a co-first

author or someone who has made a

substantial contribution to the work (see

item 5).

5. Applications must be accompanied by a

letter from the supervisor or Director of the

laboratory or service from which the work

has emanated, clearly detailing the specific

contribution made by the applicant

towards the work being presented.

6. Preference will be given to those who have

not previously been awarded CSANZ

travelling scholarships.

7. Conditions apply to successful applicants

not domiciled in Australia or New

Zealand.*

8. Late applications will NOT be considered.

Applications should be emailed to the

Honorary Secretary at [email protected] and

must include:

a) copy of submitted abstract(s) and ACC

notification of acceptance

b) brief curriculum vitae (maximum 1 page)

c) supporting letter from the supervisor or

Director

Closing Date

12 January 2018

Please note: if applicants have not received email

confirmation of receipt of their application within

1 week of submission, they should contact the

Secretariat at [email protected] immediately

Travelling Fellowships to the ACC.18

Page 8: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 8 On the pulse December 2017

Travelling Fellowship Report

I was very fortunate to receive a CSANZ

Travelling Fellowship, which afforded me the

opportunity to attend the Annual Scientific

Sessions of the American College of Cardiology 2017

in Washington DC. From late-breaking trials to

the Young Investigator awards, the conference

boasted a wide spectrum of research in

cardiology from burgeoning and eminent figures

worldwide. Attending the fellow-in-training

sessions was also beneficial in getting practical

advice from prominent clinician-researchers.

The highlight for me, however, was the

opportunity to present on the final day of the

scientific session. I was fortunate enough to have

two abstracts accepted in mini-oral moderated

sessions. The study that generated interest with

both the ACC faculty and some industry

sponsors was our findings on the accuracy of

heart rate estimation of commercially available

smart watches in arrhythmias (Apple Watch and

Fitbit). This was borne out of the clinical scenario

of patients seeking medical assistance based on

‘abnormal’ heart rate readings on their wearable

devices. Interestingly, our study showed that the

devices were accurate in certain arrhythmias

such as atrial flutter but reported varying

accuracy among patients in atrial fibrillation.

I am very grateful to the CSANZ for their

support in attending the ACC Scientific sessions.

It has provided me with inspiration for ongoing

involvement in clinical and translational

research.

Dr Anoop Koshy

Box Hill Hospital & Monash University,

Melbourne, VIC

Abstract Submission and Registration now open

Page 9: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 9 On the pulse December 2017

Travelling Fellowship Report

In May, I had the wonderful opportunity of being

invited to present the findings of my PhD at the

European Society of Cardiology, EuroHeartCare

conference in Jönköping, Sweden. The CSANZ

EuroHeartCare Travelling Fellowship made it

possible for me to accept this invitation, and it

was an honour to be the inaugural recipient.

My PhD is investigating the best way to target

basic life support training to family members of

cardiac patients, as cardiac patients are at higher

risk of future cardiac emergencies from chest

pain through to cardiac arrest. I presented the

results of my feasibility study- incorporating

basic life support training into a cardiac

rehabilitation program, in the “Sudden Cardiac

Death and Arrhythmia Management” session. I

was also given the opportunity to present recent

updates to the European Resuscitation

Guidelines in the “Be Guidelines Smart”

symposium.

The congress was well attended by nurses and

allied health professionals from all over Europe

which provided a fantastic opportunity to meet

people whose work I had read and referenced.

The research presented at the conference was of

high-quality and in addition to the scientific

sessions, included moderated poster sessions, a

fascinating clinical case session and an oral

abstract session specifically for doctoral students.

Attending the congress exposed me to the latest

international cardiac research from leading

experts and ideas and motivation to continue my

own program of research.

The CSANZ EuroHeartCare travelling fellowship

provides a fantastic opportunity to attend this

international congress and I am very grateful to

have had this support. I would highly

recommend fellow nurses and allied health

professionals to submit their work and attend

this congress in the future.

Susie Cartledge

Registered Nurse, Alfred Hospital

PhD Candidate, Department of Epidemiology

and Preventive Medicine

Melbourne, Victoria

Page 10: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 10 On the pulse December 2017

1. Applicants must be current financial

FCSANZ, Associate or Affiliate Members of

the Cardiac Society, with preference given

to early career applicants attending their

first meeting.

2. The work must have emanated from

Australia or New Zealand.

3. Applicants must have an abstract on a topic

relevant to Heart Failure, accepted for

presentation.

4. Applications must be accompanied by a

letter from the supervisor or Director of the

laboratory or service from which the work

has emanated, clearly detailing the specific

contribution made by the applicant

towards the work being presented.

5. Preference will be given to those who have

not previously been awarded a CSANZ

Travelling Scholarship.

6. Conditions apply to successful applicants

not domiciled in Australia or New Zealand.

7. Late applications will NOT be considered.

8. The Scholarship is valued at up to $3,000

9. Successful recipient must agree to present

in the next CSANZ Heart Failure Council

Programme during the CSANZ Annual

Scientific Meeting:

i. A summary of the highlights of the

meeting and an overview of the top 5

Heart Failure papers they attended at the

ISHLT Conference.

ii. An oral presentation of their abstract.

10. Successful recipient to email the Heart

Failure Council Secretary at

[email protected] confirming availability

to present in the next CSANZ Heart Failure

Council Programme (See item 9).

Applications should be accompanied by:

a) copy of submitted abstract(s) and official

notification of acceptance;

b) brief curriculum vitae;

c) supporting letter from the supervisor or

Director;

Applications should be emailed to

[email protected]

Closing Date

26 February 2018

Please note: If applicants have not received email

confirmation of receipt of their application within

1 week of submission, they should contact the

Secretariat at [email protected]

Criteria for CSANZ Heart Failure Council travel grant for the

International Society for Heart & Lung Transplantation

11—14 April, 2018, Nice, France

Page 11: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 11 On the pulse December 2017 Page 11

1. Applicants must be current financial

FCSANZ, Associate or Affiliate Members of

the Cardiac Society, with preference given

to early career applicants attending their

first meeting.

2. The work must have emanated from

Australia or New Zealand.

3. Applicants must have an abstract on a topic

relevant to Heart Failure, accepted for

presentation.

4. Applications must be accompanied by a

letter from the supervisor or Director of the

laboratory or service from which the work

has emanated, clearly detailing the specific

contribution made by the applicant towards

the work being presented.

5. Preference will be given to those who have

not previously been awarded a CSANZ

Travelling Scholarship.

6. Conditions apply to successful applicants

not domiciled in Australia or New Zealand.

7. Late applications will NOT be considered.

8. The Scholarship is valued at up to $3,000

9. Successful recipient must agree to present

in the next CSANZ Heart Failure Council

Programme during the CSANZ Annual

Scientific Meeting:

i. A summary of the highlights of the

meeting and an overview of the top 5

Heart Failure papers they attended at the

ESC Heart Failure Conference.

ii. An oral presentation of their abstract.

10. Successful recipient to email the Heart

Failure Council Secretary at

[email protected] confirming availability

to present in the next CSANZ Heart Failure

Council Programme (See item 9).

Applications should be accompanied by:

a) copy of submitted abstract(s) and official

notification of acceptance;

b) brief curriculum vitae;

c) supporting letter from the supervisor or

Director;

Applications should be emailed to

[email protected]

Closing Date

30 March 2018

Please note: If applicants have not received email

confirmation of receipt of their application within

1 week of submission, they should contact the

Secretariat at [email protected]

Criteria for CSANZ Heart Failure Council

Henry Krum Memorial

Travel Grant for the

European Society of Cardiology

—Heart Failure Meeting

26—29 May, 2018

Vienna, Austria

Page 12: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 12 On the pulse December 2017 Page 12

As a translational cardiac researcher, attend-

ance at large meetings such as the European

Society of Cardiology congress in Barcelona

this year is an important priority for me. As

such, I am grateful to the CSANZ for

supporting my attendance.

Just prior to the ESC meeting, I was one of the

invited speakers at the second international

forum of the Takotsubo Support Group, held

at the Royal Brompton Hospital in London.

This was really an introduction to me related

to the problems inherent in achieving good

patient understanding of a relatively common

condition, under the somewhat embarrassing

circumstance of limited professional

knowledge. This “knowledge vacuum”

seemed to result in widespread alarmist

concepts among patients, and I will in future

give considerable priority to the process of

dissemination of information to the

community.

To me, the ESC meeting was the usual

combination of an overwhelming breadth of

available new cardiac information, together

with the ability to focus on any particular area

of individual interest, and to discuss matters

with overseas colleagues. Apart from

presenting my work on analyses of medium-

term mortality in Takotsubo syndrome which

demonstrates that the size and haemodynamic

impact of initial episodes predict outcomes, I

liaised with key researchers from the Zurich,

Rochester, and Goteborg groups. However,

that was only a small part of the overall

benefit of the experience: there were a great

number of advances “on-show” and overall

this was like a giant information smorgasbord.

I would certainly commend attendance at this,

the world’s largest cardiac meeting to other

members of the profession. A thoroughly

enjoyable experience!

Dr Thanh Ha Nguyen

The University of Adelaide and

The Queen Elizabeth Hospital, Adelaide, SA

Travelling Fellowship Reports

Page 13: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 13 On the pulse December 2017 Page 13

The CSANZ travelling fellowship to ESC

2017 provided me with financial assistance to

travel to Barcelona to present one of my PhD

projects in Brugada Syndrome in an oral

abstract session. Our research highlights the

presence of RVOT structural abnormalities in

patients with Brugada Syndrome, more than

seen in control cohorts, but not to the degree

seen in Arrhythmogenic Right Ventricular

Cardiomyopathy (ARVC). My session was

chaired by Dr Peter Schwartz, one of the true

pioneers in the field of inherited arrhythmia

syndromes. It was a privilege to present my

research in his session.

The ESC meeting is the largest cardiology

meeting in the world and the five days were

full of training, education and networking.

The meeting was definitely beyond the scale

of anything I have previously experienced,

both locally in Australia as well as at other

international meetings. There were many

sessions running concurrently that were

appealing to any subspecialty of interest,

with late breaking clinical trials presented

such as COMPASS and CANTOS. The

session I enjoyed the most was a key note

session presenting the new guidelines for

management of valvular heart disease,

something we all see everyday as

cardiologists.

I am very grateful to the Cardiac Society for

providing me with this scholarship and

attending the meeting has fuelled my drive to

continue my ongoing research in cardiac

genetics and inherited arrhythmias.

Dr Belinda Gray

Centenary Institute,

University of Sydney and

Royal Prince Alfred Hospital, Sydney

Travelling Fellowship Reports

With the much appreciated assistance of a

Travelling Fellowship, I was able to participate

in the European Society of Cardiology annual

congress held in Barcelona at the end of

August. I presented two abstracts from our

research into vascular risk assessment,

management and outcomes among people with

atrial fibrillation in NZ primary care, which

prompted a small but enthusiastic number of

delegates to discuss the area with me as the

sessions progressed. I was also able to attend a

half-day meeting of the AF-SCREEN

international collaboration that was held prior

to the congress. The group is focussed on

improving the detection of AF around the

world and this forum allowed me to meet with

investigators from Australia, Norway and

Canada to have an initial discussion about

collaborative research into AF among

indigenous populations.

I would like to thank the Cardiac Society for

offering these fellowships. They are an

invaluable resource that not only allow us to

attend key international meetings but can open

up a range of opportunities to extend our work

and careers.

Dr Katrina Poppe

Senior Research Fellow

The University of Auckland, New Zealand

Page 14: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

Page 14 On the pulse December 2017

On the pulse For information regarding submissions for On the pulse please email [email protected] Views

expressed in On the pulse are not necessarily the views of the Cardiac Society or its Board.

New South Wales:

Roger Allan, Chair

Nigel Jepson, Secretary

New Zealand:

Paul Bridgman, Chair

Alexander Sasse, Secretary

Victoria:

Bill van Gaal, Chair

Dominica Zentner, Secretary

Queensland:

Sudhir Wahi, Chair

Sandhir Prasad, Secretary

South Australia:

Carmine de Pasquale, Chair

Julian Vaile, Secretary

Western Australia:

Rukshen Weerasooriya, Chair

Darshan Kothari, Secretary

Tasmania:

Don McTaggart, Chair

Philip Roberts-Thomson, Secretary

Regional Committees

CSANZ Board

President:

Mark Webster

President Elect:

Leonard Kritharides

Elected Board Members:

David Brieger, NSW

Will Parsonage, QLD

Matthew Worthley, SA

Jenny Deague, WA

Stephen Duffy, VIC

Luke Galligan, TAS

Affiliate Representatives:

Sally Inglis (Nursing)

Jodi Ingles (Allied Health)

Chair, Scientific

Committee:

Jonathan Kalman

Chair, Quality Standards Committee:

Derek Chew

Chair, Professional and Ethical Standards Committee:

Aravinda Thiagalingam

Paediatric Representative:

Tom Gentles

Surgical Representative:

Aubrey Almeida

National Heart Foundation

of Australia:

Garry Jennings

Chair, New Zealand

Regional Committee:

Paul Bridgman

Editor, Heart Lung and Circulation:

Robert Denniss

Honorary Secretary:

Clara Chow

Hon Asst Sec/Treasurer:

Stephen Nicholls

Chair, CPD Committee:

Richmond Jeremy

Chair, CSANZ Cardiac Imaging Council:

Sudhir Wahi

Chair, CSANZ Heart Rhythm Council:

Andrew McGavigan

Chair, CSANZ Interventional Council:

Jim Stewart

Clinical Practice Adviser:

Luke Galligan

Chair, ATC:

Leonard Kritharides

Executive Officer:

Martha McCall

CSANZ Staff:

Christine Boyle

Michael Donnici

Stephen Nicholls

Editor

Page 15: A fresh look for CSANZ€¦ · Professor Xiaowei Wang Baker Heart and Diabetes Institute, Melbourne Project Title: Towards Effective and Safe Thrombolysis and Thromboprophylaxis:

www.csanz.edu.au

Forthcoming Meetings the ACC

NORTH AMERICA

ACC18

10—12 March, 2018

Orlando, Florida

www.cardiosource.org/acc

AHA18

10—14 November, 2018

Chicago, Illinois

www.scientificsessions.americanheart.org/

EUROPE

ESC Congress 2018

25—29 August 2018

Munich, Germany

www.escardio.org

ASIA PACIFIC

APSC 2018 Congress

17 – 20 May 2018

Taipei, Taiwan

www.apsc2018.tw

CSANZ New Zealand

Annual Scientific Meeting

14—16 June 2018

Christchurch, New Zealand

Contact details:

The Conference Company

Phone: 64 9 360 1240

www.csanzasm.nz

International Clinical

Cardiovascular Genetics

Conference 2018

23—25 May, 2018

Brisbane, Queensland

Contact details:

The Conference Company

Phone: 64 9 360 1240

www.iccgconference.com

CSANZ2018

2—5 August, 2018

Brisbane, Queensland

Contact details:

The Conference Company

Phone: 64 9 360 1240

www.csanz.edu.au

ANZET18

2—5 August, 2018

Brisbane, Queensland

Contact details:

The Conference Company

Phone: 64 9 360 1240

www.csanz.edu.au

A more comprehensive list of

meetings and events can be viewed

on the Society’s website

www.csanz.edu.au

A publication of The

Cardiac Society of

Australia and New

Zealand

on the pulse

Suite 4 Level 12

189 Kent Street

SYDNEY NSW 2000

P: +61 2 9226 7900

E: [email protected]

ABN 23 003 635 505